Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
FEBS Letters|September 3, 1999
Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapyR Aqeilan, S Yarkoni, H Lorberboum-Galski
Journal of the Neurological Sciences|November 1, 1995
Interleukin-2 Pseudomonas exotoxin chimeric protein is cytotoxic to B cell cultures derived from myasthenia gravis patientsI Steinberger, T Brenner, H Lorberboum-Galski
Current Cancer Drug Targets|December 8, 2004
Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapyR Eaveri, A Ben-Yehudah, H Lorberboum-Galski
International Journal of Cancer|April 6, 2001
I.V. Administration of L-GNRH-PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude miceA Ben-Yehudah, D Prus, H Lorberboum-Galski
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1988
IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptorsM Ogata, H Lorberboum-Galski, D FitzGerald, et al.
Scientific Reports|May 18, 2016
Characteristics of Mitochondrial Transformation into Human CellsE E Kesner, A Saada-Reich, H Lorberboum-Galski
Pageof 5